OKYO Pharma Ltd - New (OKYO) EBITDA (2008 - 2025)
OKYO Pharma Ltd - New (OKYO) EBITDA from Mar 31, 2008 to Sep 30, 2025. The TTM OKYO Pharma Ltd - New (OKYO) EBITDA is -$8.52M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
OKYO Pharma Ltd - New (OKYO) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +67699.50% |
| 3 Years TTM | +813.60% |
Annual EBITDA change of OKYO Pharma Ltd - New (OKYO)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | -$9.14M | -53.75% |
| 2024 | -$20M | +21.62% |
| 2023 | -$16M | +99.25% |
| 2022 | -$8.16M | +76.77% |
| 2021 | -$4.61M | +146.57% |
| 2020 | -$1.87M | N/A |
| 2019 | $0 | N/A |
| 2018 | $0 | -100.00% |
| 2017 | -$452K | -72.43% |
| 2016 | -$1.64M | -143.83% |
| 2015 | $3.74M | -148.02% |
| 2014 | -$7.78M | +8.74% |
| 2013 | -$7.16M | -12.24% |
| 2012 | -$8.15M | +199.06% |
| 2011 | -$2.73M | -105.29% |
| 2010 | $51M | +138.15% |
| 2009 | $22M | -475.97% |
| 2008 | -$5.75M | N/A |
Comparison OKYO Pharma Ltd - New (OKYO) five years EBITDA CAGR with competitors
OKYO Pharma Ltd - New (OKYO) five years EBITDA CAGR is 894.18%.